title: Addition of Mycobacterium indicus pranii vaccine as an immunotherapeutic to standard chemotherapy in borderline leprosy: a double-blind study to assess clinical improvement (preliminary report).
authors: Department of Clinical Medicine, National JALMA Institute of Leprosy and Other Mycobacterial Diseases, Tajganj Agra, India.
authors: R
authors: R
authors: Kamal
authors: Department of Clinical Medicine, National JALMA Institute of Leprosy and Other Mycobacterial Diseases, Tajganj Agra, India.
authors: V
authors: V
authors: Pathak
authors: Department of Clinical Medicine, National JALMA Institute of Leprosy and Other Mycobacterial Diseases, Tajganj Agra, India.
authors: A
authors: A
authors: Kumari
authors: Department of Clinical Medicine, National JALMA Institute of Leprosy and Other Mycobacterial Diseases, Tajganj Agra, India.
authors: M
authors: M
authors: Natrajan
authors: Department of Clinical Medicine, National JALMA Institute of Leprosy and Other Mycobacterial Diseases, Tajganj Agra, India.
authors: K
authors: K
authors: Katoch
authors: Post Graduate Institute of Medical Education & Research, Dr Ram Manoher Lohia Hospital, New Delhi, India.
authors: H K
authors: HK
authors: Kar
mesh_terms: D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007917:Leprostatic Agents / Q000008:administration & dosage*; D015439:Leprosy, Borderline / Q000628:therapy*; D008875:Middle Aged; D009161:Mycobacterium / Q000276:immunology*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D001428:Bacterial Vaccines; D007917:Leprostatic Agents